Navigation Links
FDA Approves New Medicine BRILINTA™ (Ticagrelor) for Use in the US
Date:7/20/2011

WILMINGTON, Del., July 20, 2011 /PRNewswire/ -- AstraZeneca (NYSE: AZN) announced today that the US Food and Drug Administration (FDA) has approved BRILINTA™ (ticagrelor) tablets to reduce the rate of heart attack (myocardial infarction [MI]) and cardiovascular (CV) death in adult patients with acute coronary syndrome (ACS), compared to clopidogrel.

To view the multimedia assets associated with this release, please click: http://multivu.prnewswire.com/mnr/astrazeneca/50355/

BRILINTA, a new oral antiplatelet medicine, is indicated to reduce the rate of thrombotic cardiovascular events in patients with ACS (unstable angina [UA] non-ST-elevation myocardial infarction [NSTEMI], or ST-elevation myocardial infarction [STEMI]). BRILINTA has been shown to reduce the rate of a combined endpoint of CV death, MI or stroke compared to clopidogrel. The difference between treatments was driven by CV death and MI with no difference in stroke. In patients treated with an artery-opening procedure known as percutaneous coronary intervention (PCI), BRILINTA reduces the rate of stent thrombosis. BRILINTA has been studied in ACS in combination with aspirin. Maintenance doses of aspirin above 100 mg decreased the effectiveness of BRILINTA. Avoid maintenance doses of aspirin above 100 mg daily.

David Brennan, Chief Executive Officer, AstraZeneca said: "The FDA approval of BRILINTA is good news for patients in the United States and represents a significant milestone as we seek to help ensure ACS patients around the world have access to this innovative medicine. With over one million people affected by ACS in the US each year, the fact that physicians have a new and more effective treatment option than clopidogrel to help reduce the rate of heart attack and cardiovascular death in these patients is an important adv
'/>"/>

SOURCE AstraZeneca
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. FDA Approves Vaccines for the 2011-2012 Influenza Season
2. FDA Approves Boostrix to Prevent Tetanus, Diphtheria, and Pertussis in Older People
3. FDA Approves Arcapta Neohaler to Treat Chronic Obstructive Pulmonary Disease
4. FDA Approves XARELTO® (rivaroxaban tablets) to Help Prevent Deep Vein Thrombosis in Patients Undergoing Knee or Hip Replacement Surgery
5. FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients
6. FDA Approves First Generic Versions of the Antibiotic Levofloxacin to Treat Certain Infections
7. FDA Approves Nulojix for Kidney Transplant Patients
8. FDA Approves New Test To Help Determine if Breast Cancer Patients Are Candidates for Herceptin Treatment
9. FDA Approves First Ceramic-on-Metal Total Hip Replacement System
10. FDA Approves Redesigned Labels for Some Merck Drugs
11. FDA Approves Updates to Lillys Humalog® (insulin lispro injection [rDNA origin]) Label
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)...  Heska Corporation (NASDAQ: HSKA, "Heska" or the "Company"), a ... that Dr. Robert Grieve , the Company,s ... , executive vice president and chief financial officer, will ... being held May 30, 2013 in New York ... The Company,s presentation is scheduled to begin at 1:30 ...
(Date:5/24/2013)... 24, 2013  Sinovac Biotech Ltd. (NASDAQ: ... products in China , announced ... of Sinovac, obtained the Certificate of Good Manufacturing ... China State and Food Administration (CFDA) for its ... and its Changping filing and packaging facility. The ...
(Date:5/23/2013)... Inc. (Vanda) (NASDAQ: VNDA ) today announced that ... of the Year by the Tech Council of ... 25 th Annual Tech Awards Celebration held in ... the leaders and innovators in the technology and life science ... regions. "We are deeply honored to receive ...
Breaking Medicine Technology:Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 2Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 3Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2
... -,Phytopharm plc (LSE: PYM) ("Phytopharm" or the ... reverses the,changes in the area of the ... be presented by Dr Jonathan Brotchie, an,internationally ... International Congress of Parkinson's Disease and Movement,Disorders' ...
... the Companies' Novel Heat Shock Protein 90 ... Biological,Activity , CAMBRIDGE, Mass. and GAITHERSBURG, Md., ... Inc. (Nasdaq:INFI) and,MedImmune, Inc. (Nasdaq:MEDI) today announced ... trial of the companies' heat shock,protein 90 ...
Cached Medicine Technology:Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 2Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 3Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 4Cogane Data Presented at ‘11th International Congress of,Parkinson’s Disease and Disorders’ 5Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 2Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 3Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 4Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 5Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 6Infinity and MedImmune Present Updated Phase I Results of IPI-504,in GIST at ASCO Annual Meeting 7
(Date:5/25/2013)... viruses and parasites that affect both dogs and humans, ... than can result in liver or kidney failure -- ... veterinarian. These germs could be found in ... Susan Nelson, a clinical associate professor at Kansas State ... can be fatal, even with treatment," she said in ...
(Date:5/25/2013)... St Louis, MO (PRWEB) May 25, 2013 ... goal for the Diet Doc team of weight management professionals. ... weight fast and effectively, Diet Doc’s hCG diets ... uncontrollable factors like abuse during childhood like bullying, more control ... not directly capable of dealing with the underlying factors of ...
(Date:5/25/2013)... 25, 2013 By working diligently for ... the integration of the 2012 Lamborghini Aventador into their ... latest entrant in the list of vehicles lined by ... is all set to thrill automobile lovers in the ... and spectacular looks, the 2012 Lamborghini Aventador comes with ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 According to ... most beautiful and powerful women that ever lived. Cleopatra’s ... by some of the most powerful men in her ... beauty remedies to keep her skin glowing and fresh, ... with bees- wax, maringa oil and cyprus grass. , ...
(Date:5/25/2013)... Houston, Texas (PRWEB) May 25, 2013 ... more stressful than finals week. Increasingly, they are ... them stay awake and study. For more on ... Associates, a drug treatment facility, warns that students ... through finals” are at risk for developing a ...
Breaking Medicine News(10 mins):Health News:Hidden Dangers Dog Dog Parks 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 3Health News:Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 3Health News:Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals 2
... researchers from three disciplines are deploying thousands of tiny ... a collaborative bid to defeat Parkinson,s Disease. A ... and Health Sciences, armed with a $450,000 grant from ... the next three years using microtechnology to search for ...
... News) -- Drinking even a single glass of beer or ... of being seriously injured or dying in a crash for ... study suggests. Researchers at the University of California, San ... percent -- much lower than the legal limit in the ...
... from the Genome Institute of Singapore (GIS), an institute of ... with the Cancer Science Institute of Singapore (CSI), have discovered ... the fate of stem cells. The study, published in the ... paves the way for the development of new methods of ...
... , STANFORD, Calif. - Tobacco companies increased the advertising ... stores near California high schools with larger populations of ... Stanford School of Medicine. Although cigarette makers have ... lead researcher for the study said the data shows ...
... chronic obstructive pulmonary disease (COPD) who use inhaled corticosteroids ... a 27 percent increased risk of bone fractures, new ... were mostly men age 60 and older, the findings ... on women with COPD, a group already at a ...
... that might one day be used to block the ... disease. Their experiments offer not an immediate cure, but ... the development of this relentless neurodegenerative disorder. Huntington,s ... mutation in a single gene and marked by progressive ...
Cached Medicine News:Health News:Tiny worms head into the breach as team searches for Parkinson's treatment 2Health News:Even One Glass of Beer, Wine Boosts Car Crash Risk: Study 2Health News:Singapore scientists discover how to control fate of stem cells 2Health News:Menthol cigarettes marketed in 'predatory' pattern, Stanford study shows 2Health News:Menthol cigarettes marketed in 'predatory' pattern, Stanford study shows 3Health News:Study: Long-term inhaled corticosteroid use increases fracture risk in lung disease patients 2Health News:A step toward controlling Huntington's disease? 2Health News:A step toward controlling Huntington's disease? 3
High sensitive, specific one step immunochromatographic assay for human infectious disease...
Span Diagnostics Limited...
Malaria (P. fal.) Ag Rapid Test...
OptiMAL is a malaria test, for diagnosis and therapy control of an infection by Plasmodium species (Malaria)....
Medicine Products: